{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T09:27:45Z","timestamp":1786699665880,"version":"build-2736575974"},"reference-count":58,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med. Sci.","Medical Sciences"],"abstract":"<jats:p>Psoriasis is a chronic immune-mediated inflammatory disease in which cytokine-driven epidermal activation is accompanied by extensive remodeling of the extracellular matrix, basement membrane, and cutaneous microvasculature. Matrix metalloproteinase-9 (MMP-9; gelatinase B) may provide an important link between these structural alterations and several key features of psoriatic inflammation, including neutrophil activation, endothelial dysfunction, vascular hyperpermeability, and leukocyte recruitment. This review critically examines the biological and clinical relevance of MMP-9 across the spectrum of psoriatic disease. Particular focus is given to the cellular sources and regulation of MMP-9, its expression in lesional and non-lesional skin, and its interactions with the IL-23\/Th17, IL-17, TNF-\u03b1, IL-36, MAPK, and NF-\u03baB signaling pathways. Experimental studies support a functional neutrophil\u2013MMP-9\u2013endothelium axis in which MMP-9 can promote endothelial activation, vasodilation, vascular hyperpermeability, and leukocyte transmigration. However, this mechanistic evidence derives predominantly from experimental systems, whereas human studies mainly demonstrate associations between psoriasis and increased tissue or circulating MMP-9. The interpretation of circulating MMP-9 is further complicated by sample type, enzymatic activation state, assay heterogeneity, treatment exposure, and inflammatory and cardiometabolic confounders. Overall, MMP-9 represents a biologically possible contributor to psoriatic tissue remodeling and vascular inflammation, but its causal importance in human psoriasis remains insufficiently established. Future studies should determine whether MMP-9 can contribute to validated phenotype-specific multimarker models. At present, its clinical utility as either a biomarker or therapeutic target remains exploratory.<\/jats:p>","DOI":"10.3390\/medsci14040481","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:08:29Z","timestamp":1786694909000},"page":"481","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Matrix Metalloproteinase-9 (MMP-9) in Psoriasis: Integrating Extracellular Matrix Remodeling, Neutrophil\u2013Endothelial Crosstalk and Biomarker Evidence"],"prefix":"10.3390","volume":"14","author":[{"given":"Marta","family":"Wolosowicz","sequence":"first","affiliation":[{"name":"Thrombosis and Hemostasis Program, VERSITI Blood Research Institute, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4476-8831","authenticated-orcid":false,"given":"Slawomir","family":"Prokopiuk","sequence":"additional","affiliation":[{"name":"Faculty of Science, University of Lomza, 14 Akademicka St., 18-400 Lomza, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6870-1167","authenticated-orcid":false,"given":"Julia","family":"Nowowiejska-Purpurowicz","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Bialystok, 15-540 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8688-4171","authenticated-orcid":false,"given":"Tomasz W.","family":"Kaminski","sequence":"additional","affiliation":[{"name":"Thrombosis and Hemostasis Program, VERSITI Blood Research Institute, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s13555-021-00483-2","article-title":"Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated Comorbidities","volume":"11","author":"Menter","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Kamata, M., and Tada, Y. (2023). Crosstalk: Keratinocytes and immune cells in psoriasis. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1286344"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"m1590","DOI":"10.1136\/bmj.m1590","article-title":"Global Psoriasis Atlas. National, regional, and worldwide epidemiology of psoriasis: Systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/ijd.14864","article-title":"Global burden of psoriasis\u2014Comparison of regional and global epidemiology, 1990 to 2017","volume":"59","author":"AlQassimi","year":"2020","journal-title":"Int. J. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Furue, M., Furue, K., Tsuji, G., and Nakahara, T. (2020). Interleukin-17A and Keratinocytes in Psoriasis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21041275"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Brembilla, N.C., and Boehncke, W.H. (2023). Revisiting the interleukin 17 family of cytokines in psoriasis: Pathogenesis and potential targets for innovative therapies. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1186455"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"8639","DOI":"10.1038\/s41467-025-63791-7","article-title":"Keratinocyte-specific H4K12 lactylation drives a non-canonical IL-17-dependent signaling in psoriasis progression in mice","volume":"16","author":"Shen","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.jid.2024.02.013","article-title":"Endothelial Dysfunction in Psoriasis: An Integrative Review","volume":"144","author":"Li","year":"2024","journal-title":"J. Investig. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Simard, M., Grenier, A., Rioux, G., Tremblay, A., Blais, I., Flamand, N., and Pouliot, R. (2022). Remodeling of the Dermal Extracellular Matrix in a Tissue-Engineered Psoriatic Skin Model by n-3 Polyunsaturated Fatty Acids. Biomedicines, 10.","DOI":"10.3390\/biomedicines10051078"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Wolosowicz, M., Prokopiuk, S., and Kaminski, T.W. (2025). Matrix Metalloproteinase-9 (MMP-9) as a Therapeutic Target: Insights into Molecular Pathways and Clinical Applications. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17111425"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/bs.pmbts.2017.04.003","article-title":"Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders","volume":"148","author":"Liu","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Augoff, K., Hryniewicz-Jankowska, A., Tabola, R., and Stach, K. (2022). MMP9: A Tough Target for Targeted Therapy for Cancer. Cancers, 14.","DOI":"10.3390\/cancers14071847"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jid.2020.07.028","article-title":"Neutrophils Enhance Cutaneous Vascular Dilation and Permeability to Aggravate Psoriasis by Releasing Matrix Metallopeptidase 9","volume":"141","author":"Chen","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Wagner, M.F.M.G., Theodoro, T.R., Filho, C.A.S.M., Oyafuso, L.K.M., and Pinhal, M.A.S. (2021). Extracellular matrix alterations in the skin of patients affected by psoriasis. BMC Mol. Cell Biol., 22.","DOI":"10.1186\/s12860-021-00395-1"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Xu, K., Li, M., Hu, F., Gong, J., Liu, F., Liu, Q., and Wu, W. (2026). The role of matrix metalloproteinase 9 in immune-mediated skin diseases. Front. Immunol., 17.","DOI":"10.3389\/fimmu.2026.1802353"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Nowinka, A., Krystek, G., Gontarek, Z., G\u00f3ralczyk, M., Walig\u00f3rska, A., Walenciak, M., and Formanowicz, D. (2026). Oncometabolites and Hypoxia-Regulated Exosomes Shape HIF-Driven Macrophage Programs Across Type 2 Diabetes, Atherosclerosis, and Cancer. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27052291"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5114\/ada.2021.103383","article-title":"Decreased levels of vaspin and its potential association with cardiometabolic risk in patients with psoriasis: Preliminary results","volume":"39","author":"Kiluk","year":"2022","journal-title":"Postep. Dermatol. Alergol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Cabral-Pacheco, G.A., Garza-Veloz, I., Castruita-De la Rosa, C., Ramirez-Acu\u00f1a, J.M., Perez-Romero, B.A., Guerrero-Rodriguez, J.F., Martinez-Avila, N., and Martinez-Fierro, M.L. (2020). The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249739"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1111\/febs.70343","article-title":"Therapeutic potential of inhibitors of gelatinases MMP-2 and MMP-9 for the treatment of breast cancer","volume":"293","author":"Shoari","year":"2026","journal-title":"FEBS J."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Wolosowicz, M., Prokopiuk, S., and Kaminski, T.W. (2024). The Complex Role of Matrix Metalloproteinase-2 (MMP-2) in Health and Disease. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252413691"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Wang, Y., Chuang, C.Y., Hawkins, C.L., and Davies, M.J. (2022). Activation and Inhibition of Human Matrix Metalloproteinase-9 (MMP9) by HOCl, Myeloperoxidase and Chloramines. Antioxidants, 11.","DOI":"10.3390\/antiox11081616"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e23375","DOI":"10.1096\/fj.202201709RRRR","article-title":"IL-21 promoting angiogenesis contributes to the development of psoriasis","volume":"38","author":"Han","year":"2024","journal-title":"FASEB J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nm.3883","article-title":"The emerging role of resident memory T cells in protective immunity and inflammatory disease","volume":"21","author":"Park","year":"2015","journal-title":"Nat. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1016\/j.jid.2021.05.020","article-title":"The Psoriatic Nonlesional Skin: A Battlefield between Susceptibility and Protective Factors","volume":"141","author":"Kelemen","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/jdv.20289","article-title":"Epidermal proteomics demonstrates Elafin as a psoriasis-specific biomarker and highlights increased anti-inflammatory activity around psoriatic plaques","volume":"39","author":"Berekmeri","year":"2025","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"897","DOI":"10.47162\/RJME.62.4.02","article-title":"Novel concepts in psoriasis: Histopathology and markers related to modern treatment approaches","volume":"62","author":"Mihu","year":"2021","journal-title":"Rom. J. Morphol. Embryol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.biochi.2024.03.011","article-title":"Matrix metalloproteinase landscape in the imiquimod-induced skin inflammation mouse model","volume":"226","author":"Noddeland","year":"2024","journal-title":"Biochimie"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1038\/s41467-023-41484-3","article-title":"CREB1-driven CXCR4hi neutrophils promote skin inflammation in mouse models and human patients","volume":"14","author":"Chen","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/jid.2010.340","article-title":"Integrative responses to IL-17 and TNF-\u03b1 in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis","volume":"131","author":"Chiricozzi","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1089\/jir.2022.0225","article-title":"Interleukin-17 and Tumor Necrosis Factor Show a Functional Hierarchy to Regulate the Production of Matrix Metalloproteases by Monocytes from Patients with Psoriasis","volume":"43","author":"Springall","year":"2023","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/08820139.2018.1489831","article-title":"Serum of Patients with Psoriasis Modulates the Production of MMP-9 and TIMP-1 in Cells of Monocytic Lineage","volume":"47","author":"Bojalil","year":"2018","journal-title":"Immunol. Investig."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"9913798","DOI":"10.1155\/2021\/9913798","article-title":"Assessment of Selected Matrix Metalloproteinases (MMPs) and Correlation with Cytokines in Psoriatic Patients","volume":"2021","author":"Raczkiewicz","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"Mourits","year":"2009","journal-title":"J. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s10753-024-02103-5","article-title":"Biochanin A Ameliorates Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice by Modulating the NF-\u03baB and MAPK Signaling Pathways","volume":"48","author":"Walvekar","year":"2025","journal-title":"Inflammation"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"111679","DOI":"10.1016\/j.intimp.2024.111679","article-title":"Unconjugated bilirubin and its derivative ameliorate IMQ-induced psoriasis-like skin inflammation in mice by inhibiting MMP9 and MAPK pathway","volume":"130","author":"Bharatha","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/08977194.2024.2430205","article-title":"Plasma levels and diagnostic utility of VEGF, MMP-9 and TIMP-2 in the diagnosis of psoriasis forms","volume":"42","author":"Chihaoui","year":"2024","journal-title":"Growth Factors"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2147\/TCRM.S125595","article-title":"Narrowband ultraviolet B light treatment changes plasma concentrations of MMP-3, MMP-9 and TIMP-3 in psoriatic patients","volume":"13","author":"Niczyporuk","year":"2017","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clinbiochem.2006.10.007","article-title":"Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma","volume":"40","author":"Gerlach","year":"2007","journal-title":"Clin. Biochem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5114\/pdia.2017.66621","article-title":"ROC analysis of selected matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in psoriatic patients","volume":"35","author":"Glazewska","year":"2018","journal-title":"Postep. Dermatol. Alergol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-0716-4482-9_5","article-title":"Gelatin Zymography to Quantify Levels of MMP-2 and MMP-9 in Complex Biological Samples","volume":"2918","author":"Howell","year":"2025","journal-title":"Methods Mol. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/bjc.2016.127","article-title":"Levels of matrix metalloproteinases differ in plasma and serum\u2014Aspects regarding analysis of biological markers in cancer","volume":"115","author":"Jonsson","year":"2016","journal-title":"Br. J. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4274\/MMJ.galenos.2022.45057","article-title":"Smoking Induces the Circulating Levels of Matrix Metalloproteinase-9 and Its Association with Cardiovascular Risk in Young Smokers","volume":"37","author":"Nath","year":"2022","journal-title":"Medeni. Med. J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cca.2009.02.013","article-title":"Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome","volume":"403","author":"Gomes","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/PTT.S320016","article-title":"Psoriasis and Cardiometabolic Diseases: The Impact of Inflammation on Vascular Health","volume":"11","author":"Teklu","year":"2021","journal-title":"Psoriasis"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2147\/PTT.S471707","article-title":"Metabolic Syndrome in Psoriasis and Psoriatic Arthritis in a Mixed Race Population: Comparison of Their Prevalences","volume":"14","author":"Acioly","year":"2024","journal-title":"Psoriasis"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s13555-021-00677-8","article-title":"Role of Interleukin 36 in Generalised Pustular Psoriasis and Beyond","volume":"12","author":"Sugiura","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jaci.2016.08.056","article-title":"IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis","volume":"140","author":"Johnston","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/s41467-025-67917-9","article-title":"Dynamic neutrophil-keratinocyte communication network centered on IL-36\/TNFSF15 responses characterizes inflammatory responses in generalized pustular psoriasis","volume":"17","author":"Jiang","year":"2026","journal-title":"Nat. Commun."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.2147\/JIR.S495044","article-title":"Proteomic Profiling and Clinical Insights: The Role of MMP9 in Differentiating Psoriasis Vulgaris from Generalized Pustular Psoriasis","volume":"18","author":"Gong","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"380","DOI":"10.31138\/mjr.151024.mpr","article-title":"Matrix Metalloproteinase-9 as a Biomarker for Diagnosis and Monitor Disease Progression in Psoriatic Arthritis","volume":"36","author":"Prisila","year":"2025","journal-title":"Mediterr. J. Rheumatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13075-025-03608-6","article-title":"Investigation of serum biomarkers in rheumatoid and psoriatic arthritis patients for disease-specific signatures","volume":"27","author":"Veale","year":"2025","journal-title":"Arthritis Res. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"13541","DOI":"10.1038\/s41598-020-70327-0","article-title":"A novel biomarker of MMP-cleaved prolargin is elevated in patients with psoriatic arthritis","volume":"10","author":"Sinkeviciute","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Marshall, D.C., Lyman, S.K., McCauley, S., Kovalenko, M., Spangler, R., Liu, C., Lee, M., O\u2019Sullivan, C., Barry-Hamilton, V., and Ghermazien, H. (2015). Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0127063"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nrd4390","article-title":"Is there new hope for therapeutic matrix metalloproteinase inhibition?","volume":"13","author":"Vandenbroucke","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.bbamcr.2017.06.009","article-title":"Next generation matrix metalloproteinase inhibitors\u2014Novel strategies bring new prospects","volume":"1864","author":"Levin","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1152\/physiol.00029.2013","article-title":"Matrix metalloproteinase-9: Many shades of function in cardiovascular disease","volume":"28","author":"Yabluchanskiy","year":"2013","journal-title":"Physiology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0006-291X(03)01405-0","article-title":"Pro-MMP-9 activation by the MT1-MMP\/MMP-2 axis and MMP-3: Role of TIMP-2 and plasma membranes","volume":"308","author":"Toth","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/4\/481\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:32:02Z","timestamp":1786696322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/4\/481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":58,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["medsci14040481"],"URL":"https:\/\/doi.org\/10.3390\/medsci14040481","relation":{},"ISSN":["2076-3271"],"issn-type":[{"value":"2076-3271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]}}}